Industry leaders almost unanimously predict that China will bypass the US market by 2020. Certainly China is the engine many pharmas need to fuel booming growth but a profitable harvest is not a given. It requires shrewd strategic planning and a clear understanding of which types of opportunities reside where. The U.S.-CHINA PHARMA conference will provide an accurate overview of various growth opportunities in China. Senior executives from emerging companies, respected veterans, and influential investors and journalists will congregate to exchange ideas, make connections, and reveal key insights and case studies of companies that have successfully and profitably reaped the rewards.
BIOMEV, a bloglist of events run by iMedPub, covers all kind of biomedical conferences, meetings and forums. You can submit your event here. If you wish special promotion or publishing your abstracts / proceeding with us, please have a look at the services iMedPub provides to event organizers.